INTENSIVE CARE, HEART FAILURE AND MELATONIN

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Koşuyolu Heart Journal
Volume:11 Issue:1
INTENSIVE CARE, HEART FAILURE AND MELATONIN

INTENSIVE CARE, HEART FAILURE AND MELATONIN

Authors : Mustafa YILDIZ

Pages : 10-12

View : 15 | Download : 6

Publication Date : 2007-01-01

Article Type : Research Paper

Abstract :Melatonin insert ignore into journalissuearticles values(5-methoxy-N-acetyltryptamine); is a neurohormone that is produced in the pineal gland mainly during the night by stimulation of beta-1- and alpha-1-adrenergic receptors, and it affects a variety of heart functions including cardiac rhythms, arterial blood pressure and heart rate. Some studies suggest that melatonin may have utility in the treatment of several cardiovascular conditions such as advanced heart failure. Melatonin has been shown to be highly effective in limiting abnormal cardiac physiology and the loss of critical heart tissue resulting from ischemia/reperfusion injury. It may also be useful in reducing cardiac hypertrophy in some situations and thereby limiting the frequency of heart failure. Taken together, the findings from this studies may support the consideration of melatonin as a cardioprotective agent at the intensive care patients with advanced heart failure
Keywords : Melatonin, kalp yetmezliği, intensive care

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.